WHITE PAPER
Digital disease management for migraine
Addressing challenges and unlocking opportunities
Migraine is the second most common cause of disability around the world, impacting a billion people globally, but it’s still severely undertreated.
Many biopharma companies focusing on migraine therapies are exploring digital solutions for migraine management.
In this white paper, we explore how digital disease management solutions can revolutionize treatment of migraine for patients and ease the challenges that providers face. Download the white paper today to learn about:
- The challenges in migraine management
- Opportunities for digital to keep patients engaged, improve provider communication and generate real-world data
- The role BrightInsight's digital Disease Management Solution can play in bringing digital migraine solutions to market
Digital disease management for migraine
Biopharma and R&D